Clinical Trials
> Breast Cancer

S1207

Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer.


A5481082

Palbociclib in Hormone Receptor Postive Advanced Breast Cancer: A Prospective Multi center Non-Interventional Study.